Newsroom | 4797 results

Sorted by: Latest

Diabetes
-

Four Prime Healthcare Illinois Hospitals Recognized by U.S. News & World Report as High Performing

CHICAGO--(BUSINESS WIRE)--Four Prime Healthcare hospitals in Illinois were named High Performing in the 2025–2026 U.S. News & World Report Best Hospitals ratings - the highest distinction awarded by U.S. News for specific procedures and conditions. These four Illinois hospitals join the group of 18 total Prime Healthcare hospitals recognized by U.S. News. The ratings are based on objective, data-driven measures including patient outcomes, mortality rates, complications, and the level of nur...
-

Prime Healthcare Hospitals Recognized Nationally by U.S. News & World Report for Excellence in Patient Care

ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare is proud to announce that 18 of its hospitals have been named High Performing in the 2025–2026 U.S. News & World Report Best Hospitals ratings for outstanding performance in a wide range of procedures and conditions. These distinctions represent the highest recognition awarded by U.S. News and underscore Prime Healthcare’s commitment to delivering high-quality, evidence-based care across the country. U.S. News evaluated more than 4,400 hosp...
-

Tasso, Inc. and SheMed Provide At-Home Blood Testing to UK Women for Personalized GLP-1 Treatments

SEATTLE & LONDON--(BUSINESS WIRE)--SheMed and Tasso partner to deliver at-home blood testing for safer, personalized GLP-1 treatments....
-

RestorixHealth Announces 2025 Center Recognition Awards

METAIRIE, La.--(BUSINESS WIRE)--RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce the wound and hyperbaric center recipients of their Center Recognition Awards program for the awards period January-June 2025. These prestigious awards demonstrate a center’s commitment to the highest quality of patient care, optimal outcomes and exceptional patient satisfaction over a six-month period. “This year, we strengthened the benchmarks to better align with current...
-

Dexcom Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences: The 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 2:15 pm (EDT) The Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 2:00 pm (EDT) Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for futur...
-

Insulet Elevates Eric Benjamin to Chief Operating Officer

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the appointment of Eric Benjamin to Chief Operating Officer effective immediately. The Company also announced the appointment of Manoj Raghunandanan as Chief Growth Officer. In this expanded role, Mr. Benjamin will lead Insulet’s end-to-end growth and innovation engine, setting strategy and guiding...
-

Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on its wholly owned subsidiary Adimune, Inc. (“Adimune”), which is pioneering a DNA-based therapeutic platform designed to reprogram the immune system. Adimune’s intellectual property portfolio now includes 96 granted and 22 pending patents that are owned or exclusively licensed by Aditxt, supporting t...
-

Saudi Arabia Diabetes Drug Market Trends and Company Analysis Report 2025-2033 Featuring Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, and Novartis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Saudi Arabia Diabetes Drug Market Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Saudi Arabia Diabetes Drug Market is anticipated to grow to US$ 1.33 billion by 2033, from US$ 773.6 million in 2024, growing at a CAGR of 6.22% from 2025 to 2033 This growth is due to an increase in the prevalence of diabetes, enhanced awareness, government healthcare expenditure, and acceptance of new therapeutic agents like SGLT2 inh...
-

Saudi Arabia Blood Glucose Device Market Trends Report 2025-2033 | Rising Diabetes Incidence, Health Awareness, and Technological Advances Propel Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Saudi Arabia Blood Glucose Device Market Size & Trends 2025-2033" report has been added to ResearchAndMarkets.com's offering. The Saudi Arabia Blood Glucose Device Market is projected to grow at US$ 143.96 Million in 2024 to US$ 259.8 Million in 2033 at a CAGR of 6.78% over the forecast period 2025-2033. The market is fueled by the increasing incidence of diabetes, increasing awareness about health, and government initiatives for early diagnosis and self-blood...
-

Family Heart Foundation Announces Partnership With Seven Leading Healthcare Systems to Accelerate Screening in People With Cardiovascular Disease Who Have Been Identified by the FIND Lp(a) Initiative

FERNANDINA BEACH, Fla.--(BUSINESS WIRE)--Family Heart Foundation's partnership with seven healthcare systems accelerates screening of high Lp(a) in people with cardiovascular disease....